LianBio

NASDAQ: LIAN · Real-Time Price · USD
0.32
0.00 (0.31%)
At close: Jan 16, 2025, 10:00 PM

LianBio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a
Cost of Revenue
1M 525.7K
Gross Profit
-1M -525.7K
Operating Income
-125.35M -195.57M
Interest Income
n/a 243.32K
Pretax Income
-110.62M -195.78M
Net Income
-110.29M -196.3M
Selling & General & Admin
65.6M 36.88M
Research & Development
59.76M 158.69M
Other Expenses
n/a -455K
Operating Expenses
124.2M 195.57M
Interest Expense
n/a 243K
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
125.2M 195.57M
Income Tax Expense
-332.6K 518K
Shares Outstanding (Basic)
107.92M 34.39M
Shares Outstanding (Diluted)
107.92M 34.39M
EPS (Basic)
-1.02 -5.71
EPS (Diluted)
-1.02 -5.71
EBITDA
-124.35M -195.04M
EBIT
n/a -195.54M
Depreciation & Amortization
1.01M 525K